Understand the oncology partnering landscape using intelligence from 2,955 real-world collaboration and licensing deals.
Oncology Collaboration and Licensing Deals 2021-2026 provides comprehensive intelligence on 2,955 partnering deals involving oncology assets, technologies and development programs.
Oncology remains one of the most active areas of pharmaceutical and biotechnology partnering, with companies using collaboration and licensing to access novel targets, therapeutic modalities, development programs and commercial opportunities across a rapidly evolving treatment landscape.
The report brings this extensive deal activity together in one resource, enabling users to understand who is partnering, which oncology opportunities are attracting interest, how transactions are structured, what financial terms have been disclosed and how dealmaking differs across therapeutic indications, technologies and stages of development.
Rather than simply providing a list of transactions, the report combines market-wide deal analysis with financial benchmarking, leading dealmaker intelligence, detailed transaction records and access to publicly available contract documents where available.
It provides a practical intelligence and benchmarking resource for business development, licensing, search and evaluation, corporate strategy, R&D strategy, competitive intelligence and legal teams involved in oncology partnering.
This provides real-world reference points for internal benchmarking, opportunity assessment, deal preparation and negotiation.
Financial benchmarks are most useful when interpreted alongside the structure and circumstances of comparable transactions rather than as standalone averages, and the report provides the underlying deal intelligence needed to establish that context.
The report analyzes partnering by therapeutic indication and therapeutic target, enabling users to move beyond broad oncology benchmarks and focus on transactions most relevant to a particular program or strategic interest.
Combined with analysis by technology and development stage, this helps users identify more meaningful comparable transactions and prospective partners.
Identify comparable oncology transactions, prospective partners and relevant deal structures.
Search and Evaluation teams
Understand which companies are actively seeking oncology opportunities across relevant indications, technologies, targets and development stages.
Biotechnology Companies Seeking Partners
Identify organizations with demonstrated interest in comparable oncology assets and technologies.
Corporate and R&D Strategy teams
Understand how competitors and prospective partners are building oncology portfolios through external innovation.
Competitive and Market Intelligence teams
Track partnering activity by company, indication, target, development stage and technology to understand evolving strategic priorities.
Legal and Transaction teams
Review publicly available contracts and precedent agreement structures to support transaction preparation and negotiation.
Senior Management and Portfolio Strategy teams
Understand where capital, partnering attention and external innovation activity are being concentrated across the oncology landscape.
The briefing applies the underlying oncology deal intelligence to the customer's own asset, technology, indication, target or partnering objectives.
Depending on requirements, this can include relevant comparable transactions, prospective partners, competitor activity, development-stage analysis, deal structures, financial benchmarks, royalty analysis, contract insights and other intelligence selected specifically for the client's situation.
Oncology Collaboration and Licensing Deals 2021-2026 provides comprehensive intelligence on 2,955 partnering deals involving oncology assets, technologies and development programs.
Oncology remains one of the most active areas of pharmaceutical and biotechnology partnering, with companies using collaboration and licensing to access novel targets, therapeutic modalities, development programs and commercial opportunities across a rapidly evolving treatment landscape.
The report brings this extensive deal activity together in one resource, enabling users to understand who is partnering, which oncology opportunities are attracting interest, how transactions are structured, what financial terms have been disclosed and how dealmaking differs across therapeutic indications, technologies and stages of development.
Rather than simply providing a list of transactions, the report combines market-wide deal analysis with financial benchmarking, leading dealmaker intelligence, detailed transaction records and access to publicly available contract documents where available.
It provides a practical intelligence and benchmarking resource for business development, licensing, search and evaluation, corporate strategy, R&D strategy, competitive intelligence and legal teams involved in oncology partnering.
Understand the oncology partnering landscape
The report analyzes oncology dealmaking from 2021 to 2026, including:
- Trends in oncology partnering by year
- Deal activity by deal type
- Industry sector
- Stage of development at the time of partnering
- Technology type
- Therapeutic indication
- Most active oncology dealmakers
- Leading deals by disclosed value
- How oncology partnering activity is evolving
Benchmark oncology deal financials
Financial terms in oncology can vary significantly according to the asset, development stage, technology, competitive landscape, rights granted and overall transaction structure.The report provides dedicated analysis of disclosed financial terms, including:
- Headline deal values
- Upfront payments
- Milestone payments
- Royalty rates
This provides real-world reference points for internal benchmarking, opportunity assessment, deal preparation and negotiation.
Financial benchmarks are most useful when interpreted alongside the structure and circumstances of comparable transactions rather than as standalone averages, and the report provides the underlying deal intelligence needed to establish that context.
Identify leading oncology dealmakers and prospective partners
The report identifies the most active companies in oncology partnering and provides extensive transaction histories that enable users to investigate their previous activity.This can help users identify:
- Companies actively seeking oncology opportunities
- Prospective licensing and collaboration partners
- Organizations repeatedly partnering in relevant cancer indications
- Companies active at relevant stages of development
- Dealmakers demonstrating interest in particular targets, technologies or therapeutic modalities
- Competitors pursuing related external innovation strategies
Compare partnering activity across oncology indications and targets
Oncology encompasses a very broad range of cancer indications, biological targets and therapeutic approaches, each with different scientific, clinical and commercial dynamics.The report analyzes partnering by therapeutic indication and therapeutic target, enabling users to move beyond broad oncology benchmarks and focus on transactions most relevant to a particular program or strategic interest.
Combined with analysis by technology and development stage, this helps users identify more meaningful comparable transactions and prospective partners.
Understand how oncology agreements are structured
The report includes collaboration, licensing, development, research and other partnering transactions.Depending on the transaction and available disclosure, users can investigate areas including:
- Rights granted and retained
- Research and development responsibilities
- Licensing rights
- Exclusivity
- Geographic rights
- Intellectual property
- Development and regulatory obligations
- Manufacturing and supply responsibilities
- Commercialization rights
- Financial consideration
- Milestones and royalties
- Governance
- Term and termination provisions
Learn from real-world contract documents
Where publicly available, the report provides access to underlying contract documents for selected oncology transactions.These agreements can provide substantially more detail than headline announcements alone, enabling users to examine how companies have documented areas such as:
- Scope of rights
- Development obligations
- Intellectual property
- Exclusivity
- Financial terms
- Milestone triggers
- Royalty provisions
- Commercialization rights
- Termination and other negotiated provisions
Comprehensive oncology deal directory
The report includes a comprehensive directory of 2,955 oncology collaboration and licensing deals, providing an extensive resource for identifying relevant precedent transactions.Deals can be reviewed by:
- Company
- Technology type
- Therapeutic indication or target
- Contract availability
Who should use this report?
Business Development and Licensing teamsIdentify comparable oncology transactions, prospective partners and relevant deal structures.
Search and Evaluation teams
Understand which companies are actively seeking oncology opportunities across relevant indications, technologies, targets and development stages.
Biotechnology Companies Seeking Partners
Identify organizations with demonstrated interest in comparable oncology assets and technologies.
Corporate and R&D Strategy teams
Understand how competitors and prospective partners are building oncology portfolios through external innovation.
Competitive and Market Intelligence teams
Track partnering activity by company, indication, target, development stage and technology to understand evolving strategic priorities.
Legal and Transaction teams
Review publicly available contracts and precedent agreement structures to support transaction preparation and negotiation.
Senior Management and Portfolio Strategy teams
Understand where capital, partnering attention and external innovation activity are being concentrated across the oncology landscape.
Turn market-wide oncology intelligence into company-specific insight
For qualifying customers, the analyst can also provide a Customized Executive Partnering Briefing alongside the report.The briefing applies the underlying oncology deal intelligence to the customer's own asset, technology, indication, target or partnering objectives.
Depending on requirements, this can include relevant comparable transactions, prospective partners, competitor activity, development-stage analysis, deal structures, financial benchmarks, royalty analysis, contract insights and other intelligence selected specifically for the client's situation.
Table of Contents
Executive SummaryChapter 1 - Introduction
Chapter 2 - Trends in oncology dealmaking
Chapter 3 - Financial deal terms for oncology partnering
Chapter 4 - Leading oncology deals and dealmakers
Chapter 5 - Oncology contract document directory
Chapter 6 - Oncology dealmaking by therapeutic target
Deal directory
Table of figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 1cBio
- 1ST Biotherapeutics
- 2seventy bio
- 3B Pharmaceuticals
- 3D Medicines
- 3SBio
- 3T Biosciences
- 4baseCare
- 4bases
- 4C Biomed
- 4D Path
- 4D Pharma
- 9 Meters Biopharma
- 10X Genomics
- 20n Bio
- 48Hour Discovery
- 111
- A*STAR Agency for Science
- Technology and Research
- A*STAR Bioprocessing Technology Institute
- A*STAR’ Institute of Molecular and Cell Biology
- A2 Biotherapeutics
- A3P Biomedical
- Aadi Bioscience
- Aarvik Therapeutics
- Abbisko Therapeutics
- Abbott Laboratories
- Abbvie
- Abcam
- AbCellera Biologics
- Abdul Latif Jameel Health
- AbelZeta Pharma
- Abera Bioscience
- Abilita Bio
- Abilita Therapeutics
- Abintus Bio
- Ablaze Pharmaceuticals
- ABL Bio
- Ab Magnitude Ventures
- Abound Bio
- Abpro
- Abramson Cancer Center
- AbSci
- AbTherx
- ABVC BioPharma
- Abveris
- ABX
- Abzena
- Academic Breast Cancer Consortium
- Accelerated Biosciences
- Accent Therapeutics
- Access to Comprehensive Genomic Profiling Coalition
- Acclinate
- Accuray
- AccuStem Sciences
- Acepodia
- Acerand Therapeutics
- Achilles Therapeutics
- Acibadem University
- Acrivon Therapeutics
- Acrotech Biopharma
- Actimed Therapeutics
- Actinium Pharmaceuticals
- ACT Therapeutics
- Actuate Therapeutics
- Acuitas Therapeutics
- Adagene
- AdAlta
- Adaptimmune
- Adaptive Biotechnologies
- Adaptive Research
- Adcendo
- ADC Therapeutics
- AdhereTech
- Adicet Bio
- Adimab
- Adlai Nortye
- Advanced Radiation Therapy
- Advancell
- Aerogen
- Aethlon Medical
- Aethon Therapeutics
- Aetion
- Affimed Therapeutics
- Affini-T Therapeutics
- Affinia Therapeutics
- AFT Pharmaceuticals
- AGC Biologics
- Agena Bioscience
- Agencja Badan Medycznych
- Agendia
- Agenus Bio
- AgeX Therapeutics
- Agilent Technologies
- AgonOx
- AiCure
- Aidence
- Aidoc
- Aignostics
- AIkido Pharma
- AI Longevity
- AimedBio
- AIM ImmunoTech
- Ainos
- Aion Therapeutic
- AI Proteins
- Aitia
- AiVita Biomedical
- Ajax Therapeutics
- Ajinomoto
- Ajou University Medical Center
- Akamis Bio
- Akari Therapeutics
- Akeso Biopharma
- Akoya Biosciences
- AKSO Biopharmaceutical
- Aktis Oncology
- Alamar Biosciences
- Alaya.bio
- Alberta Health Services
- Alcedis
- Alchemab
- Alessa Therapeutics
- Aleta Biotherapeutics
- Alex’s Lemonade Stand Foundation
- Alida Biosciences
- Alivio Health
- ALK Positive
- Alkyon Therapeutics
- Allarity Therapeutics
- Allelica
- Alliance Foundation Trials
- Alligator Bioscience
- Allist Pharma
- Allogene Therapeutics
- Alloplex Biotherapeutics
- Allorion Therapeutics
- Alloy Therapeutics
- Almac Diagnostics
- Almac Discovery
- Almirall
- Alpha Biopharma
- Alphamab Biopharmaceuticals
- Alphamab Oncology
- Alpha Tau Medical
- Alpine Immune Sciences
- Altamira Therapeutics
- Alteogen
- Alverno Clinical Laboratories
- Alvotech
- ALX Oncology
- Amasa Therapeutics
- Amazon Web Services
- Amber Pharmacy
- Ambry Genetics
- American Association for Cancer Research
- American Lung Association
- American Society of Clinical Oncology (ASCO)
- American Type Culture Collection (ATCC)
- Amgen
- AmMax Bio
- Amneal Pharmaceuticals
- Amoy Diagnostics
- Amphista Therapeutics
- Amplia Therapeutics
- AmplifyBio
- AnchorDx
- Angiex
- Angiogenesis Foundation
- Angle
- AnHeart Therapeutics
- Anima Biotech
- Anivive Lifesciences
- Anixa Biosciences
- Anji Pharma
- Anju Software
- Ankyra Therapeutics
- Anocca AB
- Anova Enterprises
- Anpac Bio-Medical Science
- Antares Therapeutics
- Antengene
- Antharis Therapeutics
- Anthony Nolan
- Anthropic
- Antisoma Therapeutics
- Antiverse
- Apeiron Biologics
- Apexigen
- Apmonia Therapeutics
- Apollo Healthcare
- Apollomics
- Apollon Formularies
- Apollo Therapeutics
- Appia Bio
- Applied BioMath
- Applied Biomedical Science Institute
- Applied Cells
- AppliedVR
- Aprea Therapeutics
- Aptorum Group
- Aptose Biosciences
- Aqemia
- Araris Biotech
- ARase Therapeutics
- Arbor Biotechnologies
- Arcellx
- Arch Oncology
- Arcturus Therapeutics
- Arcus Biosciences
- Ardigen
- argenx
- Ariceum Therapeutics
- Arima Genomics
- Arovella Therapeutics
- Arrayus Technologies
- ArriVent Biopharma
- Arrotex Pharmaceuticals
- Arsenal Biosciences
- ARTBIO
- Artelo Biosciences
- ArteraAI
- Arthrosi Therapeutics
- Artidis
- Artios Pharma
- Artiva Biotherapeutics
- Artizan Biosciences
- ARTMS Product
- Arvinas
- Asan Medical Center
- Ascentage Pharma
- Asher Bio
- Asher Biotherapeutics
- Asieris MediTech
- Asieris Pharmaceuticals
- AskGene Pharma
- Astellas Pharma
- Astellas Pharma US
- Astex Pharmaceuticals
- AstraZeneca
- Astrin Biosciences
- Asymchem Laboratories
- Atara Biotherapeutics
- Athebio
- Athenex
- Athira Pharma
- Atlas Antibodies
- AtomVie Global Radiopharma
- Atossa Therapeutics
- ATP
- ATUM
- AUM Biosciences
- Aurigene Discovery Technologies
- Australian and New Zealand Children’s Haematology / Oncology Group
- Australian Nuclear Science and Technology Organisation
- Autolomous
- Autolus
- Autonomous Therapeutics
- Avacta
- Avatamed
- Avectas
- Avenzo Therapeutics
- AVEO Oncology
- Avera Health
- Aviceda Therapeutics
- Avicenna Biosciences
- Aviko Radiopharmaceuticals
- AVM Biotechnology
- Axcelead Drug Discovery Partners
- Azra AI
- AZ Sint Lucas Hospital
- Bach Biosciences
- Baili Biopharmaceutical
- BAKX Therapeutics
- BAMF Health
- Banner MD Anderson Cancer Center
- Barbara Ann Karmanos Cancer Institute
- Barrow Neurological Institute
- Bayer
- Baylor College of Medicine
- Baylor Scott and White Research Institute
- BC Cancer Agency
- BCM Europe
- BC Platforms
- B dot Medical
- Beactica
- Beartooth Therapeutics
- Bebig
- Be Biopharma
- BEC
- Becton Dickinson
- BeiGene
- Beijing Genomics Institute (BGI)
- Beijing InnoCare Pharma
- Beijing Xisike Clinical Oncology Research Foundation
- Belharra Therapeutics
- Bellicum Pharmaceuticals
- Bend Bioscience
- BenevolentAI
- Bennu Pharmaceuticals
- BeOne Medicines
- BerGenBio
- Beroni Group
- Be The Match BioTherapies
- Beth Israel Deaconess Medical Center
- Betta Pharmaceuticals
- Beverly Hills Cancer Center
- Beyond Cancer
- Beyondspring Pharmaceuticals
- BGN Technologies
- Bicycle Therapeutics
- BigHat Biosciences
- Binghamton University
- BinnoPharm
- Bio-Manguinhos/Fiocruz
- Bio-Rad Laboratories
- Bio-Sourcing
- Bio-Techne
- Bio-Thera Solutions
- BioAgilytix
- Bioarchitech
- biOasis Technologies
- BioAtla
- Biobot Surgical
- Biocare Medical
- Biocartis
- Biocept
- BioCheetah
- BioCina
- BioCity Biopharma
- Biocodices
- Biocon
- BioCopy
- Biocytogen
- Biodesix
- Biodexa Pharmaceuticals
- BioEclipse Therapeutics
- BioElpida
- Biofidelity
- Biofourmis
- Biofrontera Pharma
- Biogen
- Biogenar
- Biognosys
- Biohaven Pharmaceuticals
- BioIntelliSense
- BioInvent
- BioKey
- BiolineRX
- Biological Dynamics
- Biolojic Design
- BioMark Diagnostics
- Biomarker Collaborative
- Biomedical Advanced Research and Development Authority
- Biomedical Catalyst Fund (UK)
- BioMed X Innovation Center
- Biomica
- Biomunex Pharmaceuticals
- Bionaut Labs
- Biond Biologics
- BiOneCure Therapeutics
- BioNex Solutions
- BioNexus Gene Lab
- BioNova Pharmaceuticals
- BioNTech
- Biortus Biosciences
- BioSenic
- Biosidus
- Biosion
- Biositu Pharmaceutical Technology
- Biosplice
- Biostage
- Biostar
- BioStrand
- BioTheryX
- Biotheus
- BioTuring
- BioVaxys
- BioVolume
- bitBiome
- BJ Bioscience
- Black Diamond Therapeutics
- Blackford
- Blacksmith Medicines
- Blackstone
- Blank Bio
- Blau Pharma
- Bliss Biopharmaceutical
- Blu Biotech
- Bluebridge Technologies
- Blue Earth Diagnostics
- Blue Note Therapeutics
- Blueprint Medicines
- BobcatBio
- Boehringer Ingelheim
- Bolt Biotherapeutics
- Boostimmune
- Boryung Pharmaceutical
- BostonGene
- Boston Immune Technologies and Therapeutics
- Boston Pharmaceuticals
- Boston University
- Bot Image
- Boundless Bio
- BPGbio
- Bpifrance
- Bracco Imaging
- BRAIN Biotech
- BrainLAB
- Brainomix
- Brazlex Medical Genetics
- Breakthrough Genomics
- Brenus Pharma
- BriaCell Therapeutics
- BriaPro Therapeutics
- BridgeBio Pharma
- Bridge Biotherapeutics
- Bridge Medicines
- BridGene Biosciences
- Brigham and Women's Hospital
- BrightPath Biotherapeutics
- Bright Peak Therapeutics
- Brii Biosciences
- Bristol-Myers Squibb
- Broad Institute
- Brooklyn ImmunoTherapeutics
- Broome Oncology
- Bugworks
- Burning Rock
- Busan Paik Hospital
- BWXT Medical
- BYOMass
- Byondis
- C-RAD
- C2i Genomics
- C4 Therapeutics
- Calbiotech
- Calian Group
- Calico
- Calidi Biotherapeutics
- Califia Pharma
- California Institute for Regenerative Medicine
- Calithera Biosciences
- Calyx
- Camargo Pharmaceutical Services
- Cambridge Quantum Computing
- Can-Fite BioPharma
- Canadian Cancer Society
- Canadian Institutes of Health Research
- Canadian Nuclear Laboratories
- CanariaBio
- Cancer and Blood Specialty Clinic
- CancerCare
- Cancer Focus Fund
- Cancer Hospital Chinese Academy of Medical Sciences
- Cancer Prevention and Research Institute of Texas
- Cancer Research Horizons
- Cancer Research Institute
- Cancer Research UK
- Cancer Science Institute of Singapore
- CancerVax
- CancerX initiative
- Candel Therapeutics
- Cannabics Pharmaceuticals
- CanProbe
- Cantex Pharmaceuticals
- Caravan Biologix
- Cardiff Oncology
- Cardiff University
- CARE
- Care Access Research
- Caribou Biosciences
- Carina Biotech
- Caring Cross
- Caris Life Sciences
- Carisma Therapeutics
- Carnegie Mellon University
- Carrick Therapeutics
- Carrum Health
- CARsgen
- Cartexell
- CARTI Cancer Center
- Cartography Biosciences
- Case Western Reserve University
- CASI Pharmaceuticals
- Castle Biosciences
- Catalent
- Catalyst Clinical Research
- Catamaran Bio
- Catholic University Leuven
- Ceapro
- Cedars-Sinai Medical Center
- Cedilla Therapeutics
- CeGaT
- Celanese
- Celcuity
- Celest Therapeutics
- Cell-Easy
- Cellares
- CellBion
- CellCarta
- Cellectis
- Cellevolve Bio
- Cellinfinity Bio
- Cellipont Bioservices
- Cellistic
- Cellkey
- CellMax Life
- CellOrigin Biotech
- Cellpath
- CELLphenomics
- Cell Point
- Cell Therapy Manufacturing Center
- Celltrion
- CellType
- Cellular Biomedicine
- CellVax Therapeutics
- Cellworks
- Celularity
- Cencora
- Cend Therapeutics
- Centene
- Centre for Clinical Cancer Research
- Centre for Imaging Technology Commercialization
- Centre for Probe Development and Commercialization
- Centre Hospitalier Universitaire Vaudois (CHUV)
- Centre Leon Berard
- Century Therapeutics
- Cerecor
- Cerner
- Certara
- Certis Oncology Solutions
- Cevec Pharmaceuticals
- CG Oncology
- Champalimaud Foundation
- Champions Oncology
- Chao Center
- Charite Universitatsmedizin Berlin
- Charles River Laboratories
- Checkmate Pharmaceuticals
- Checkpoint Therapeutics
- Chemify
- Chengdu Baiyu Pharmaceutical
- Children's Hospital Boston
- Children's Hospital Los Angeles
- Children's National Hospital
- Children's Tumor Foundation
- Children´s Oncology Group (COG)
- Chime Biologics
- Chimeric Therapeutics
- China Grand Pharmaceutical
- Chinese University of Hong Kong
- Chinook Therapeutics
- Chiome Bioscience
- Chipscreen NewWay Biosciences
- Chong Kun Dang
- Chonnam National University
- Christus Health
- ChromaCode
- Chugai Pharmaceutical
- Cidara Therapeutics
- CiMaas
- Cimeio Therapeutics
- Cincinnati Children’s Hospital Medical Center
- Cipla
- Circio
- Circle Pharma
- Cirna Diagnostics
- Citius Oncology
- Citius Pharmaceuticals
- City of Hope
- Cizzle Biotech
- CK Life Sciences
- Clarity Pharmaceuticals
- Clarix
- Clarus Therapeutics
- Clavius Pharmaceuticals
- ClearNote Health
- Cleave Therapeutics
- Cleveland Clinic
- Cleveland University Hospitals
- Clinical Laserthermia Systems (CLS)
- Clinical Research Data Sharing Alliance
- Clinica Universidad Navarra
- Clinigen
- Clinscience
- Clintrex Research
- Clover Biopharmaceuticals
- Clovis Oncology
- CMG Pharmaceutical
- CNAO Foundation
- CNS Pharmaceuticals
- Code Ocean
- Coeptis Pharmaceuticals
- Coeptis Therapeutics
- Cofactor Genomics
- Cognizant
- Coherus Biosciences
- CoImmune
- Collaborations Pharmaceuticals
- Colorado Melanoma Foundation
- Columbia University
- Columbia University Medical Center
- CombiGene
- Combotope Therapeutics
- Community Clinical Oncology Research Network
- Compass Therapeutics
- Complete Genomics
- Complix
- Compugen
- ConcertAI
- Concr
- Congenica
- Congruence Therapeutics
- Connect
- Context Therapeutics
- Convergent Bioscience
- Convergent Therapeutics
- Corbus Pharmaceuticals
- Core Biotherapeutics
- CorePath Laboratories
- CorePlus
- Cornell University
- Cortex Design
- Cortice Biosciences
- Cosmos
- Cosylab
- COTA
- Covant Therapeutics
- Coya Therapeutics
- Creative Biolabs
- Crescendo Biologics
- Crescent Biopharma
- Crinetics
- CRISPR Therapeutics
- Criterium
- Cromos Pharma
- Crosscope
- Crown Bioscience
- CRT Pioneer Fund
- CryoPort
- CSEM Centre Suisse d'Electronique et de Microtechnique
- CSPC Megalith Biopharmaceutical
- CSPC Pharmaceutical Group
- CStone Pharmaceuticals
- CTMC
- CTSI Oncology Solutions
- CTTQ-Akeso Biomed
- Cue Biopharma
- Cullgen
- Cullinan Oncology
- Culmination Bio
- Cumberland Pharmaceuticals
- Curadh MTR
- Curasight
- Curatis
- Curebase
- CureMatch
- CureMD
- CureMetrix
- CURE Pharmaceutical
- CureScience
- CureVac
- Curiox Biosystems
- Curis
- Curium
- Curta
- Curtana Pharmaceuticals
- CvergenX
- Cybrexa Therapeutics
- Cyclenium Pharma
- Cyclica
- CYduct Diagnostics
- Cypre
- Cytea Bio
- Cytecare Cancer Hospitals
- Cytocom
- Cytodyn
- CytoImmune Therapeutics
- CytoLynx Therapeutics
- CytoMed Therapeutics
- CytomX Therapeutics
- CytoReason
- CytoSite Bio
- Cytovance Biologics
- Cytovation
- CYTOVIA Therapeutics
- DAAN Biotherapeutics
- DAAN Bio Therapeutics
- Daewoong Pharmaceutical
- Daiichi Sankyo
- Dalton Pharma Services
- Dana-Farber Cancer Institute
- Dana Farber Partners Cancer Care
- Danaher
- Danish Cancer Society Research Center
- Dante Labs
- Danuo Science Group
- Dartmouth College
- DarwinHealth
- Datavant
- Day One Biopharmaceuticals
- DCx Biotherapeutics
- Debiopharm
- Dechra Pharmaceuticals
- Deciphera Pharmaceuticals
- Deep Bio
- Deepcell
- Deep Lens
- Deerfield Management
- Defence Therapeutics
- Deimos Biosciences
- Delfi Diagnostics
- Delphi Diagnostics
- Denovo Biopharma
- Densitas
- Department of Defense
- Department of Veterans Affairs
- Derm-Biome Pharmaceuticals
- Detect-Ion
- DeuteRx
- Deverra Therapeutics
- Dewpoint Therapeutics
- DiaCarta
- Diaccurate
- Diakonos Oncology
- Dialectic Therapeutics
- DIAN Diagnostics
- Diaprost
- Diatech Pharmacogenetics
- DISCO Pharmaceuticals
- Discovery Life Sciences
- Dispatch Bio
- DisperSol Technologies
- Diverse Biotech
- Dizal Pharmaceutical
- DLH Holdings
- DNAnexus
- Dolbey
- DoMore Diagnostics
- Dong-A Pharmaceutical
- DotBio
- DoveTree Medicines
- Dr. Reddy's Laboratories
- Dragonfly Therapeutics
- Dragon Sail Pharmaceutical
- Dren Bio
- Droplet Biosciences
- DualityBio
- Duke University
- Duke University Health System
- Dxcover
- DxVx
- Dyve Biosciences
- Earendil Labs
- Early is Good
- EchelonDx
- Eckert & Ziegler
- Eczacibasi Pharmaceuticals
- Edison Oncology
- Editas Medicine
- EDX Medical
- eFFECTOR Therapeutics
- Eikon Therapeutics
- Eilean Therapeutics
- EirGenix
- Eisai
- Eisana
- Elekta
- Elektrofi
- Element Biosciences
- Elephas
- Elevar Therapeutics
- ElevateBio
- Elevation Oncology
- ELIAS Animal Health
- Elicio Therapeutics
- Eli Lilly
- Elix
- Elligo Health Research
- Ellipses Pharma
- Elpis Biopharmaceuticals
- Elpiscience
- Elthera
- EmendoBio
- Emercell
- Emergence Therapeutics
- EmeritusDX
- Emit Imaging
- Emmaus Life Sciences
- Emory University
- Empyrean Medical Systems
- Enara Bio
- Endeavor BioMedicines
- Endevica Bio
- Endoluxe
- Energenx Medical
- EnGeneIC
- Engimmune Therapeutics
- Engitix
- Enlivex
- Enodia Therapeutics
- Enosi Therapeutics
- ENPICOM
- Ensem Therapeutics
- Enterprise Ireland
- Enveric Biosciences
- Envisagenics
- Enzolytics
- EOC Pharma
- Epic
- EpicentRx
- Epic Sciences
- EpimAb Biotherapeutics
- Epiphany Dermatology
- Epitopea
- EpiVax Therapeutics
- Epizyme
- EQRx
- Er-Kim
- Erasca
- Erasmus University Medical Center
- ERS Genomics
- ErVimmune
- Escugen
- Esperovax
- ESSA Pharma
- Essen University Hospital
- Esteve
- Etcembly
- Eterna Therapeutics
- eTheRNA immunotherapies
- Eucure Biopharma
- Euformatics
- Euratom
- Eureka Eurostars
- Eureka Therapeutics
- Eurobio Scientific
- Eurofins Discovery
- European Innovation Council
- European Institute of Oncology (EIO)
- European Laboratory for Particle Physics
- European Organization for Research and Treatment of Cancer
- Eutilogics
- Evariste
- Evaxion Biotech
- Evercyte
- Everest Medicines
- Evergreen Theragnostics
- Eversana
- EVerZom
- Evexta Bio
- Evinova
- Evive Biotechnology
- Evogene
- Evolent Health
- EvolveImmune Therapeutics
- Evopoint Biosciences
- EVOQ Therapeutics
- Evotec
- EVQLV
- Ewopharma
- Exacis Biotherapeutics
- Exact Sciences
- Exai Bio
- Excellmab
- Excellos
- ExCellThera
- Excelra
- Exelixis
- Exigent Research
- EXINI Diagnostics
- ExonanoRNA
- EXoPERT
- Exopharm
- Exosome Diagnostics
- Exousia Pro
- Experimental Drug Development Centre
- Expert Systems Inc
- Exscientia
- Exuma Biotech
- Eyam Vaccines and Immunotherapeutics
- F-Star Therapeutics
- Factor Bioscience
- Factorial Biotechnologies
- FairJourney Biologics
- Falco
- Family Reach
- Faraday Pharmaceuticals
- Farcast Biosciences
- FatiAbGen
- Federation Bio
- Fennec Pharmaceuticals
- Ferring Pharmaceuticals
- Ferronova
- Ferrum Health
- Fibrogen
- Fidelion Diagnostics
- Fight Colorectal Cancer
- FineImmune Biotechnology
- FivepHusion
- Flagship Biosciences
- Flagship Pioneering
- Flame Biosciences
- Flare Therapeutics
- Flatiron Health
- Florida Atlantic University Research
- Florida Cancer Specialists & Research Institute
- Florida Theranostics
- Focal Healthcare
- Follicular Lymphoma Foundation
- Food and Drug Administration (FDA)
- ForDoz Pharma
- Foreseen Biotechnology
- Foresee Pharmaceuticals
- Foresight Diagnostics
- Foresite Capital
- FORMA Therapeutics
- Formosa Pharmaceuticals
- Formycon
- Fortis Therapeutics
- Fortrea
- FortySix Venture Capital
- FORUS Therapeutics
- Fosun Pharmaceutical
- Foundation Medicine
- Fox Chase Cancer Center
- Francis Crick Institute
- Fred Hutchinson Cancer Research Center
- Freenome
- Friends of Cancer Research
- Frontier Medicines
- Fujifilm Diosynth Biotechnologies
- Fujifilm medical systems
- Fulgent Genetics
- Fulgent Pharma
- Full-Life Technologies
- Fuse Oncology
- Fusion Pharmaceuticals
- Future Fields
- FutureGen Biopharm
- Fuzionaire Diagnostics
- FyoniBio
- G1 Therapeutics
- G42 Healthcare
- Gadeta
- Gaeta Therapeutics
- Gain Therapeutics
- Galapagos
- Galaxy Health Network
- Galecto
- Galmed Pharmaceuticals
- Galvanize Therapeutics
- Gamida Cell
- Gandeeva Therapeutics
- Gastro-Intestinal Research Foundation
- Gateway for Cancer Research
- GC
- GC Cell
- GC Genome
- GE Healthcare
- GEICAM
- Geisinger Health System
- Gemelli Teaching Hospital
- GEn1E Lifesciences
- GeneCentric Therapeutics
- GeneCraft
- GeneData
- Genelux
- Genentech
- GeneQuantum Healthcare
- General Inception
- General Proximity
- Generate Biomedicines
- Geneseeq
- GenesisCare
- Genesis Pharma
- Genesis Research and Development
- Genesis Therapeutics
- Genetic Leap
- Genetic Technologies
- Genevant Sciences
- Genewiz
- Genezen
- GenFleet Therapeutics
- Genhouse Bio
- Genialis
- Genmab
- Genocea Biosciences
- Genome and Company
- Genome Diagnostics
- Genome Insight
- Genomic Testing Cooperative
- Genomill Health
- Genomoncology
- Genoscience
- Genprex
- GenScript Biotech
- GenScript ProBio
- Genuv
- Georgetown University
- George Washington University
- Georgiamune
- German Cancer Research Center
- Gestalt Diagnostics
- Gicell
- GigaMune
- GI Innovation
- Gilead Sciences
- Ginkgo BioWorks
- GlamorousAI
- Glenmark Pharmaceuticals
- Glenmark Pharmaceuticals S.A.
- GlobalBio
- Global Cancer Technology
- Global Coalition for Adaptive Research
- Global Liver Institute
- Gloria Biosciences
- GlycoMantra
- GlycoNex
- Glycostem Therapeutics
- Glycotope Biotechnology
- Glycovax Pharma
- Glykos
- Glytherix
- GNS Healthcare
- GO2 Foundation for Lung Cancer
- GOG Foundation
- GO Therapeutics
- Government of Ireland
- GPCR Therapeutics
- Gracell Biotechnologies
- Grail
- Granite Bio
- Graviton Bioscience
- Greenlight Biosciences
- Greenwich LifeSciences
- Grey Wolf Therapeutics
- Grid Therapeutics
- GRIT Biotechnology
- Gritstone Bio
- Groupe d'OncologieRadiothérapie Tête Et Cou
- GSK
- GT Apeiron Therapeutics
- GT Biopharma
- GT Medical Technologies
- Guangzhou Fanen Biotechnology
- Guangzhou Ruianbo Pharmaceutical Technology
- Guangzhou Ruiao Biopharmaceutical Technology
- Guardant Health
- Guerbet
- Guohong Guokang (Beijing) Health Technology Development
- GV20 Therapeutics
- H3 Biomedicine
- Hackensack Meridian Health
- Hadassah Medical Center
- HaemaLogiX
- Hainan Sinotau Pharmaceutical
- Haisco Pharmaceutical
- Halberd
- HalioDx
- HALO Precision Diagnostics
- Halozyme Therapeutics
- HanAll Biopharma
- HanAll Pharmaceuticals
- HanchorBio
- Handa Therapeutics
- Hande Sciences
- Handok Pharmaceuticals
- Hangzhou CNK Therapeutics
- Hangzhou Zhongmei Huadong Pharmaceutical
- Hanmi Pharmaceutical
- HanX Biopharmaceuticals
- Harbinger Health
- Harbour Biomed
- Harpoon Therapeutics
- Harvard Medical School
- Harvard University
- HavaH Therapeutics
- HAYA Therapeutics
- Haystack Oncology
- HCW Biologics
- HDT Bio
- HealthMyne
- HebeCell
- Hebei Senlang Biotechnology
- Hebrew University of Jerusalem
- Heidelberg Pharma
- Heligenics
- Helio Genomics
- Helio Health
- Helmholtz Zentrum Munchen
- Helsinn Healthcare
- Helsinn Therapeutics
- Hematology-Oncology Associates of Central New York
- Hemogenyx
- Henan Cancer Hospital
- Hengenix Biotech
- Henlius Biotech
- Henry M. Jackson Foundation
- Hepion Pharmaceuticals
- Hera BioLabs
- Heska
- HiberCell
- HIBio
- Hibiscus BioVentures
- HiFiBio
- Hikma Pharmaceuticals
- Hillstream BioPharma
- HiloProbe
- HistoIndex
- Hisun BioRay
- HitGen
- HK inno.N
- Hoffmann La Roche
- Hokkaido University
- Holobeam Technologies
- Hologic
- Honeycomb Biotechnologies
- Hookipa Pharma
- Horizon Europe
- Horizon Oncology
- Hospital Clinic of Barcelona
- Hospital for Sick Children
- Hoth Therapeutics
- HotSpot Therapeutics
- Hox Therapeutics
- HTG Molecular Diagnostics
- Huadong Medicine
- Huahui Health
- Huma
- Humana
- Humanitas University
- Hummingbird Bioscience
- Hutchmed
- Huyabio International
- Hyloris Pharmaceuticals
- I-mab
- Iambic Therapeutics
- IASO Biotherapeutics
- Iaso Pharmaceuticals
- IBA
- Ibex Medical Analytics
- iBio
- iCAD
- Icahn School of Medicine at Mount Sinai
- ICAN
- Ichnos Glenmark Innovation
- Ichnos Sciences
- Icon
- IDEAYA Biosciences
- IDEOlogy Health
- Idorsia
- ID Solutions
- Ifowonco Informatics
- IGM Biosciences
- Ikena Oncology
- Ikonisys
- Ikonopedia
- Iksuda Therapeutics
- Iktos
- Ildong Pharmaceutical
- Illumina
- ImaginAb
- IMBdx
- Immagene
- Immatics Biotechnologies
- Immedica
- Immix Biopharma
- Immorna
- Immunai
- Immune-Onc Therapeutics
- Immuneel Therapeutics
- Immuneering
- ImmuneOncia Therapeutics
- ImmuneOnco Biopharmaceuticals
- Immune Therapeutics
- Immunicom
- ImmunityBio
- ImmunoAdoptive Cell Therapy
- Immunocore
- ImmunoGen
- ImmunoGenesis
- Immunome
- Immunomedics
- Immunomic Therapeutics
- ImmunoPrecise Antibodies
- ImmunoScape
- Immunovia
- ImmuPharma
- Immutep
- ImmVira
- IMPACT-AML
- IMPACT Therapeutics
- Imperial College London
- IMU Biosciences
- Imugene
- IMV
- Imvaq Therapeutics
- In4Derm
- IN8bio
- Inceptor Bio
- Incyclix Bio
- Incyte
- Indapta Therapeutics
- Indaptus Therapeutics
- Indiana Biosciences Research Institute
- Indiana University
- Indica Labs
- Indivumed
- InduPro Therapeutics
- Industrial Centre for Artificial Intelligence Research in Digital Diagnostics
- Infinimmune
- Infinitusbio.AI
- Inform Diagnostics
- Inhibikase Therapeutics
- Inhibitor Therapeutics
- Inhibrx
- Inivata
- INmune Bio
- Innate Pharma
- InnDura Therapeutics
- Innolake Biopharm
- Innoplexus
- Innosuisse
- Innovate BC
- Innovate UK
- Innovation Norway
- Innovative Cellular Therapeutics
- Innovative Medicines Initiative (IMI)
- Innovent Biologics
- Innsena
- Inocras
- Inovio
- Inserm
- Insilico Medicine
- InSitu Biologics
- InSphero
- Inspirna
- Instil Bio
- Institut Bergonie
- Institut Curie
- Institute for Follicular Lymphoma Innovation
- Institute for Molecular Medicine Finland
- Institute for Systems Biology
- Institute of Cancer Research
- Institute of Oncology Research
- Institut Gustave Roussy
- Institut Paoli-Calmettes
- Intas Pharmaceuticals
- Integra Connect
- Integral Molecular
- Integrated Biosciences
- Integrated DNA Technologies
- Integra Therapeutics
- Intellia Therapeutics
- Intelligent Medical Objects
- Intelliseq
- Intensity Therapeutics
- Intermountain Healthcare
- Intermountain Precision Genomics
- International Association for the Study of Lung Cancer
- International Centers for Precision Oncology Foundation
- Intima Bioscience
- Intonation Research Laboratories
- Invasight
- Invectys
- Invenio Imaging
- Invenra
- Inventum Genetics
- inviCRO
- invIOs
- InVirtuoLabs
- Invitae
- InVivoScribe
- InxMed
- IO Biotech
- iOncologi
- iOnctura
- Ionetix
- Ionis Pharmaceuticals
- Ionova
- Iovance Biotherapeutics
- Ipsen
- IQVIA
- IRBM
- Isofol Medical
- Isologic Innovative Radiopharmaceuticals
- Isotopia Molecular Imaging
- Italian Association for the Study of Pancreas
- iTeos Therapeutics
- Iterion Therapeutics
- ITM Isotopen Technologien
- IUCT
- Ix Therapeutics
- Jackson Laboratory
- Jacobio Pharma
- Jacobio Pharmaceuticals
- Janssen Biotech
- Janssen Pharmaceuticals
- Janssen Pharmaceutica NV
- Janssen Research & Development
- Janux Therapeutics
- Japanese Foundation for Cancer Research
- Jazz Pharmaceuticals
- Jefferson Healthcare
- Jemincare
- Jenga Biosciences
- Jenthera Therapeutics
- Jerome Canady Research Institute for Advanced Biological and Technological Sciences
- Jiangsu Aosaikang Pharmaceutical
- Jiangsu Chia Tai Tianqing Pharmaceutical
- Jiangsu Hansoh Pharmaceutical
- Jiangsu Hengrui Medicine
- Jiangsu Hengrui Pharmaceuticals
- J Ints Bio
- JMT-Bio
- Jnana Therapeutics
- Johannes Gutenberg University
- John Hopkins University School of Medicines
- Johns Hopkins University
- Johnson & Johnson
- Johnson & Johnson Innovation
- Josep Carreras Leukaemia Research Institute
- Jounce Therapeutics
- Joyo Pharmatech
- JSR Life Sciences
- Juniper Biologics
- Juniper Biosciences
- Junshi Biosciences
- Juntendo University
- Jupiter Bioventures
- Jura Bio
- Juri Biosciences
- JW Biotechnology
- JW Therapeutics
- K2 Therapeutics
- K2bio
- Kahn-Sagol-Maccabi
- KAHR Medical
- Kainos Medicines
- Kairos Pharma
- Kalbe Genexine Biologics
- KaliVir Immunotherapeutics
- Kantonsspital Baselland
- Kanvas Biosciences
- Karkinos Healthcare
- Karolinska Institute
- Karolinska University Hospital
- Kartos Therapeutics
- Karyopharm Therapeutics
- Kazia Therapeutics
- KDx Diagnostics
- Kelonia Therapeutics
- Kelun-Biotech Biopharmaceutical
- Kephera Diagnostics
- Keros Therapeutics
- Kestrel Therapeutics
- Keymed Biosciences
- Kezar Life Sciences
- Kheiron Medical Technologies
- Kibur Medical
- Kincell Bio
- Kineta
- Kings College London
- Kinnate Biopharma
- Kiromic Biopharma
- Kissei Pharmaceutical
- Kite Pharma
- Kiyatec
- Knight Therapeutics
- KOMO Biosciences
- Korea Drug Development Fund
- Korea Institute of Radiological and Medical Sciences
- Kovina Therapeutics
- Krankenhaus Nordwest
- Kriya Therapeutics
- Kronos Bio
- KSQ Therapeutics
- Kumquat Biosciences
- Kura Oncology
- Kuva Labs
- Kymera Therapeutics
- Kyoto University
- Kyowa Hakko Kirin
- kyron.bio
- LabConnect
- LabGenius
- LabGenius Therapeutics
- Laboratory Corporation of America
- Laboratory of Pathology
- Laevoroc Oncology
- La Jolla Institute for Allergy & Immunology
- LaNova Medicines
- Lantern Pharma
- Lantheus Holding
- LarmorBio
- Lassen Therapeutics
- Latvian Institute of Organic Synthesis
- LaunXP Biomedical
- Lava Therapeutics
- Lawson Health Research Institute
- Leal Health
- Leap Therapeutics
- Lee's Pharmaceutical
- Lee Health
- Lee Moffitt Cancer Center
- Legend Biotech
- LegoChem Biosciences
- Lehigh Valley Health Network
- Leica Biosystems
- Leo Cancer Care
- LEO Pharma
- Lepu Biopharma
- Les Laboratoires Servier
- Leucid Bio
- Leukemia & Lymphoma Society
- LeukoCom
- Leveragen
- LG Chem
- LianBio
- Libera Bio
- Life Raft Group
- Lifespin
- LifeStrands Genomics
- LIfT BioSciences
- LigaChem Biosciences
- Ligand Pharmaceuticals
- Light Horse Therapeutics
- Lightpoint Medical
- Limbus AI
- Lindis Biotech
- Lineage Cell Therapeutics
- Linical
- Link Cell Therapies
- LinKinVax
- Lion TCR
- Lipomedix Pharmaceuticals
- Liquid Biosciences
- Lisata Therapeutics
- Little Warrior Foundation
- Livzon Mabpharm
- Lixte Biotechnology
- Logomix
- Longwood University
- Lonza
- LOTTE Biologics
- Lotus Pharmaceuticals
- Loxo Oncology
- LTZ Therapeutics
- Lubrizol
- Lucence
- Lucid Diagnostics
- Lukas Biomedical
- LumaBridge
- Luminary Therapeutics
- Lunaphore
- Lundquist Institute
- Lung Cancer Foundation of America
- Lung Cancer Initiative
- Lung Cancer Research Foundation
- LUNGevity Foundation
- Lunit
- Lupagen
- Lyell Immunopharma
- Lymphoma Academic Research Organization
- Lyvgen Biopharma
- M2Gen
- M42
- MaaT Pharma
- MabCare Therapeutics
- Mablink Bioscience
- Mabtech
- Mabwell Bioscience
- mAbXience
- Maccabi Healthcare Services
- Macomics
- Macrogenics
- MagBio Genomics
- MagCorp
- Magle Chemoswed
- MagnaPharm Group
- Magnet Biomedicine
- MAIA Biotechnology
- Maine Medical Center
- Mainz Biomed
- Manhattan BioSolutions
- MapKure
- Marengo Therapeutics
- Maria Curie-Sklodowska University
- Marker Therapeutics
- Mark Foundation for Cancer Research
- Mary Crowley Cancer Research Center
- Massachusetts General Hospital
- Massachusetts Institute of Technology
- Massachusetts Life Sciences Center
- Mass General Brigham
- Massive Bio
- Mater Research
- Mawi DNA Technologies
- Max-Delbruck Center for Molecular Medicine
- Maxcyte
- Max Planck Institute for Multidisciplinary Sciences
- Mayo Clinic
- McKesson
- McMaster University
- McQuade Center for Strategic Research and Development
- MD Anderson Cancer Center
- MDimune
- MDxHealth
- Medable
- Medac
- Medexus Pharmaceuticals
- Medial EarlySign
- Medical College of Georgia
- Medical College of Wisconsin
- Medical Research Council
- Medical University of Graz
- Medical University of Innsbruck
- Medical University South Carolina
- Medicenna Therapeutics
- Medicines Patent Pool Foundation
- MEDiC Life Sciences
- Medicus Pharma
- Medidata Solutions
- MediGene
- MediLink Therapeutics
- MediSix Therapeutics
- Medison Pharma
- Medivir
- Medolife Rx
- MedPacto
- Medsenic
- Medshine Discovery
- MEDSIR
- Meharry Medical College
- Meitheal Pharmaceuticals
- Melanoma Research Alliance
- Melax Technologies
- Memorial Sloan Kettering Cancer Center
- Memo Therapeutics
- Menarini
- Mendus
- Mentice
- Merck and Co
- Merck KGaA
- Merck Sharpe & Dohme
- Mereo BioPharma
- Meridian Bioscience
- Mersana Therapeutics
- Merus
- Mestag Therapeutics
- Mestastop
- Metabolon
- Metafora Biosystems
- Metagenomi
- MetaSight Diagnostics
- ME Therapeutics
- METiS TechBio
- Metis Therapeutics
- MetOx Technologies
- Mevion Medical Systems
- MGFB
- MGI Tech
- Microba Life Sciences
- Microbiotica
- Micronoma
- Microsoft
- Microviable Therapeutics
- Miltenyi Biotec
- Mimetas
- Minaris Regenerative Medicine
- MindPeak
- MindRank AI
- Minghui Pharmaceutical
- MiNK Therapeutics
- Minotaur Therapeutics
- Mirada Medical
- MIRA PRECISION HEALTH
- Mirati Therapeutics
- Mirror Biologics
- MiRXES
- Mission Bio
- Mitsubishi Tanabe Pharma
- MJH Life Sciences
- Moderna
- ModeX Therapeutics
- Molcure
- Molecular Health
- Molecular Targeting Technologies
- Molecular Templates
- Moleculin Biotech
- Molecure
- MOMA Therapeutics
- Mongoose Bio
- Monoceros Biosystems
- Monopar Therapeutics
- Montai Therapeutics
- Monte Rosa Therapeutics
- Moonlight Bio
- MorphoSys
- Mor Research Applications
- Mosaic ImmunoEngineering
- Mosaic Therapeutics
- Mount Sinai Health System
- MP Group,
- MPM Capital
- mProbe Laboratories
- MSD
- MS Pharma
- MThera Pharma
- Multidisciplinary Association for Psychedelics Studies
- MultiPlan
- Multiple Myeloma Research Foundation
- Multitude Therapeutics
- Mundipharma
- Munich Technical University
- Mustang Bio
- MyBiotics Pharma
- Myeloid Therapeutics
- Mymetics
- myNEO
- Myovant Sciences
- Myriad Genetics
- Myricx Bio
- Mythic Therapeutics
- Nagoya University Graduate School of Medicine
- NAMSA
- Nanjing KAEDI Biotech
- Nanjing King-friend Biochemical Pharmaceutical
- Nanjing Leads Biolabs
- Nanobiotix
- Nanocarry Therapeutics
- Nanoform
- NanoMab Technology
- Nanosoft Polymers
- Nanostics Precision Health
- NanoString Technologies
- NaNotics
- NanoVation Therapeutics
- NanoView Biosciences
- NantOmics
- Napo EU
- Napo Pharmaceuticals
- Nascent Biotech
- Natera
- National Cancer Care Alliance
- National Cancer Center
- National Cancer Center of Japan
- National Cancer Centre Singapore
- National Cancer Institute
- National Center for Advancing Translational Sciences (NCATS)
- National Comprehensive Cancer Network (NCCN)
- National Health Service
- National Heart
- Lung and Blood Institute
- National Institute for Bioprocessing Research and Training
- National Institute for Public Health and the Environment
- National Institute of Neurological Disorders and Stroke
- National Institutes of Health
- National Institutes of Health Clinical Center
- National Research Council of Canada
- National Resilience
- National University Cancer Institute
- National University of Ireland
- Galway (NUI Galway)
- Nationwide Children’s Hospital
- Nautilus Biotech
- Naval Medical Research Center
- Naveris
- Navidea Biopharmaceuticals
- Navigo Proteins
- Navrogen
- NAYA Biosciences
- nCage Therapeutics
- NDS Corporation
- Nectin Therapeutics
- NED Biosystems
- Nektar Therapeutics
- Nelum Pharma
- NeoCura Bio-Medical Technology
- Neogap Therapeutics
- Neogene Therapeutics
- Neogenomics
- NeoImmuneTech
- Neoleukin Therapeutics
- Neomorph
- NeOnc Technologies
- NeoPharm
- NeoPhore
- Neoregen Biotech
- Neosoma
- NeoX Biotech
- NeraCare
- Nerviano Medical Sciences
- Netherlands Cancer Institute
- NetraMark
- NETRIS Pharma
- Neuberg Diagnostics
- NeuCen BioMed
- Neupharma
- Neurix
- Neurochase
- Neurocrine Biosciences
- Neutron Therapeutics
- Neuvogen
- Newcastle University
- New Day Diagnostics
- New Horizon Health
- Newsoara Biopharma
- NewStem
- New York Cancer & Blood Specialists
- New York University Langone Health
- New York University School of Medicine
- Nexcella
- Neximmune
- NextCure
- NEXT Oncology
- NextPoint Therapeutics
- NextRNA Therapeutics
- Nference
- NGM Biopharmaceuticals
- Nico
- NiKang Therapeutics
- Nilogen Oncosystems
- Nimble Therapeutics
- Niowave
- Nippon Kayaku
- Nippon Shinyaku
- Nkarta Therapeutics
- Nobelpharma
- Noetik
- Nona Biosciences
- Nonacus
- Nordic Nanovector
- Nordic Society of Gynaecological Oncology
- Norgine
- Noria Therapeutics
- Normunity
- North Carolina State University
- NorthStar Medical Radioisotopes
- Northwest Biotherapeutics
- Northwestern University
- NorthX Biologics
- Norwegian Cancer Society
- Notable Labs
- Nouscom
- NovAccess Global
- NovAliX
- Novarad
- NovaRock Biotherapeutics
- Novartis
- NovaScan
- Nova Scotia Health Innovation Hub
- Novatim Immune Therapeutics
- Novellus Biopharma
- Novellus Therapeutics
- Novelty Nobility
- Novocure
- Novogene
- Novo Nordisk
- Novotech
- NRG Oncology
- nRichDX
- Nuance Pharma
- Nucleai
- Nucleix
- Nuclidium
- NuclixBio
- Nucs AI
- Numab
- Nuntius Therapeutics
- NuProbe
- Nurix Therapeutics
- Nurosene
- Nuvation Bio
- Nuvectis Pharma
- Nvidia
- NX Development
- NXgenPort
- Nykode Therapeutics
- NYU Grossman School of Medicine for Preclinical and Clinical Research
- NYU Langone Medical Center
- Oasmia Pharmaceutical
- OBI Pharma
- Ocean Biomedical
- Odeon Therapeutics
- Odimma Therapeutics
- Ohio State University
- Olatec Therapeutics
- Olema Oncology
- Olimmune
- Olink Proteomics
- Olivia Newton-John Cancer Research Institute
- Omega Therapeutics
- Omico
- OmiCure
- OmniAb
- OmniaBio
- OmniSpirant
- Ona Therapeutics
- Oncidium Foundation
- Onco-Innovations
- OncoAssure
- OncoBay Clinical
- OncoBone Ventures
- OncoC4
- Oncoclinicas
- OncoCyte
- Oncode Institute
- Oncodesign
- OncoDNA
- Oncoheroes Biosciences
- OncoHost
- Oncology Group
- Oncology Pharma
- Oncompass Medicine
- OncoMyx Therapeutics
- OncoNano Medicine
- Onconova Therapeutics
- Oncopeptides
- OncoResponse
- Oncorus
- OncoSec Medical
- Oncoshot
- Oncosyne
- Oncotelic
- OncoVerity
- Oncovet
- Oncovir
- Oncovita
- OncoX BioPharma
- Oncternal Therapeutics
- OnCusp Therapeutics
- OncXerna Therapeutics
- OneOncology
- OneThree Biotech
- ONK Therapeutics
- Ono Pharmaceutical
- Onsite Women’s Health
- Ontada
- Ontario Institute for Cancer Research
- Onward Therapeutics
- OpenBench
- OpenEye Scientific Software
- Optellum
- Optieum Biotechnologies
- Optimeos Life Sciences
- Orange Grove Bio
- Orano Med
- OrbiMed Asia Partners
- Orbit Discovery
- Ordaos Bio
- Oregon Health Sciences University
- Oregon Oncology Specialists
- Oregon Therapeutics
- Organon
- Ori Biotech
- ORIC Pharmaceuticals
- OrigiMed
- Orion
- Orionis Biosciences
- Orna Therapeutics
- Oscotec
- OSE Immunotherapeutics
- Osel
- Oslo University Hospital
- OSR Holdings
- Ossium Health
- Ostentus Therapeutics
- OTR Therapeutics
- Otsuka
- Ottawa Health Research Institute
- Ottawa Hospital Research Institute
- Ottimo Pharma
- Outpace Bio
- Ovation
- Owkin
- Owlstone Medical
- Oxford Biomedica Solutions
- Oxford BioTherapeutics
- Oxford Cancer Biomarkers
- Oxford Drug Design
- Oxford Nanopore Technologies
- Oxford Vacmedix
- Oxyrane UK
- Ozette Technologies
- Pacific Biosciences
- Pacific Cancer Care
- PACT Pharma
- Pacylex
- Paige
- Palleon Pharmaceuticals
- Paltown Development Foundation
- Panbela Therapeutics
- Pancreatic Cancer Early Detection Consortium
- Pangea Biomed
- Panolos Bioscience
- Papyrus Therapeutics
- Paradigm
- Paragon Therapeutics
- Parexel
- Parthenon Therapeutics
- Partnership for Accelerating Cancer Therapies
- Partner Therapeutics
- PathAI
- PathomIQ
- Pathos AI
- Paul Scherrer Institute
- PAVmed
- PCI Biotech
- PDRadiopharma
- PDS Biotechnology
- Pearl Bio
- Pelthos Therapeutics
- Penn Medicine
- Pennsylvania State University
- Pepscan
- PeptiDream
- Peptone
- Peptron
- Percheron Therapeutics
- Persephone Biosciences
- Personal Genome Diagnostics
- Personalis
- PersonGen BioTherapeutics
- Perspective Therapeutics
- Perthera
- Peter MacCallum Cancer Institute
- Pfizer
- Pfizer Canada
- Phanes Therapeutics
- PharmAbcine
- PharmaEssentia
- PharmaJet
- PharmaLogic
- PharmaMar
- Pharmanovia
- Pharmapark
- Pharus Diagnostics
- Phase Genomics
- PHC
- Phebra
- Phenomic AI
- PhenoVista Biosciences
- Pheon Therapeutics
- Phillips-Medisize
- Philochem
- Philogen
- Phio Pharmaceuticals
- PhoreMost
- Phost’in Therapeutics
- Photocure ASA
- PhotonPharma
- Phrontline Biopharma
- Phytronix Technologies
- Pieces Technologies
- Pierian
- PierianDx
- Pieris Pharmaceuticals
- Pierre Fabre
- Pillar Biosciences
- PineTree Therapeutics
- Pint Pharma
- Pionyr Immunotherapeutics
- Piramal
- Planet Innovation
- Plan France Relance
- PlantForm
- PlantPraxis Biotecnologia
- Plectonic Biotech
- Pluristyx
- Plus Therapeutics
- PlusVitech
- PMV Pharma
- Point32Health
- POINT Biopharma
- Polarean Imaging
- Polaris Group
- PolarisQB
- Polifarma
- PolyPid
- Pompeu Fabra University
- Portage Biotech
- Porton Biologics
- Porton Pharma Solutions
- Poseida Therapeutics
- PPD
- Precipio Diagnostics
- Precirix
- PreciseDx
- Precision BioSciences
- Precision for Medicine
- Precision Molecular
- Precision NeuroMed
- Predicine
- Predictive Oncology
- Pregene Biopharma
- PreludeDx
- Prelude Therapeutics
- PreMIT
- Prenetics
- Presage Biosciences
- Prestige BioPharma
- Previse
- Prime Medicine
- Princess Margaret Hospital
- Princeton University
- Prisma Health
- PRISM BioLab
- Privo Technologies
- ProBioGen
- ProEn Therapeutics
- Profluent Bio
- ProfoundBio
- Profound Medical
- Progenetics
- PrognomIQ
- Prokarium
- Prolium Bioscience
- Promega
- Propanc Biopharma
- ProPath
- Propella Therapeutics
- Prophase Labs
- Proscia
- Prosoma Digital Therapeutics
- Prostate Cancer Clinical Trials Consortium
- Protean BioDiagnostics
- ProteinTech
- ProteoMediX
- Proteros biostructures
- Protocol First
- ProTom International
- Providence
- Providence Cancer Institute
- Providence Therapeutics
- PSI CRO
- PsiVac
- PT Elion Medika
- PT Etana Biotechnologies
- Puma Biotechnology
- Purdue Research Foundation
- Pure Biologics
- PureForm Global
- Pure MHC
- PureTech Health
- Purisys
- Purple Biotech
- Pyramid Biosciences
- Pyxis Oncology
- Q-Gen Cell Therapeutics
- Q BioMed
- QDX
- QED Therapeutics
- QIAGEN
- Qilu Pharmaceutical
- Qlarity Imaging
- QT Imaging
- Quadri Pharmaceuticals
- Qualigen
- Quantgene
- Quantum Leap Health Care Collaborative
- Qubit Pharmaceuticals
- Quebec Consortium for Drug Discovery
- Quebec Heart and Lung Institute
- Queen Mary University of London
- Queensland Institute of Medical Research (QIMR)
- Queensland University of Technology
- Queens University Belfast
- Quercis Pharma
- Quest Diagnostics
- Qure Healthcare
- Qurient
- R-Pharm
- Race Oncology
- Radboud University Nijmegen
- Radiance Biopharma
- Radiomedix
- Radionetics Oncology
- Radiopharm Theranostics
- Rady Children's Institute for Genomic Medicine
- Rain Oncology
- Rakovina Therapeutics
- Rakuten Medical
- Rambam Medical Center
- RamSoft
- Ranok Therapeutics
- Rappta Therapeutics
- Rarecells
- Ratio Therapeutics
- RaySearch Laboratories
- RayzeBio
- Realm IDx
- Receptor.AI
- Recro Pharma
- Recurrent Respiratory Papillomatosis Foundation
- Recursion
- RedHill Biopharma
- Redwood Bioscience
- Redx Pharma
- RefleXion Medical
- Refuge Biotechnologies
- Regen BioPharma
- Regeneron Pharmaceuticals
- Regional Cancer Institute of Montpellier
- Regnum
- Regor Therapeutics
- Relation Therapeutics
- Relay Therapeutics
- RemeGen
- Remepy
- Remix Therapeutics
- Renato Dulbecco Foundation
- RenovoRx
- Renown Institute for Health Innovation
- Repare Therapeutics
- Repertoire Immune Medicines
- Replay
- Replimune
- ReproCell
- Reset Pharmaceuticals
- Res Nova Bio
- Resolution Bioscience
- RevealDx
- Reveal Genomics
- ReviR Therapeutics
- Revitope Oncology
- Revolution Medicines
- Rgene
- Rgenta Therapeutics
- Ribon Therapeutics
- Rigel Pharmaceuticals
- Rising Tide Foundation
- Rivaara Immune
- RK Pharma
- Roche
- Roche Diagnostics
- Roche Molecular Systems
- Rockefeller University
- Rocket VR Health
- Roivant Sciences
- Rondo Therapeutics
- Roswell Park Cancer Institute
- Royal Marsden Hospital
- Royal Philips Electronics
- Rubix LS
- RubrYc Therapeutics
- Rutgers Cancer Institute of New Jersey
- Rutgers University
- Rxilient Biotech
- Ryvu Therapeutics
- Rznomics
- SAGA Diagnostics
- Saga University
- Sai Life Sciences
- Sairopa
- Salarius Pharmaceuticals
- Salk Institute
- Samsung Bioepis
- Samsung Biologics
- Samyang Biopharmaceuticals
- Sana Biotechnology
- SandboxAQ
- Sandoz
- Sanford Burnham Institute
- Sanofi
- San Raffaele Hospital
- SanReno Therapeutics
- Sant Joan de Déu-Barcelona Children’s Hospital
- Sanwa Kagaku Kenkyusho
- Sapien Biosciences
- Sapience Therapeutics
- Sapu Bioscience
- Sarah Cannon Research Institute
- Sarcoma Oncology Center
- Sartorius Stedim Biotech
- Satisfai Health
- SATT Nord
- Scailyte
- Scancell
- Scanslated
- Scenic Biotech
- Schrodinger
- SciBase
- SciClone Pharmaceuticals
- Science 37
- ScienceMachine
- Scintomics
- Scorpion Therapeutics
- Screenpoint Medical
- Scribe Therapeutics
- Scripps Research Institute
- Seagen
- Seattle Children's Therapeutics
- Seattle Genetics
- Sebela Pharmaceuticals
- Sebia
- Secarna Pharmaceuticals
- Sectra
- Seed Therapeutics
- SeekIn
- Segmed
- Seibersdorf Laboratories
- Selexis
- SELLAS Life Sciences Group
- Selvita
- Sema4
- SEngine Precision Medicine
- Senhwa Biosciences
- Sensei Biotherapeutics
- Senti Biosciences
- Sentinel Diagnostics
- Seoul National University
- SequMed
- SeraNovo
- Sermonix Pharmaceutical
- Serotiny
- Sesen Bio
- Seven and Eight Biopharmaceuticals
- SevenScore Pharmaceuticals
- Shanghai Affinity Biopharmaceutical
- Shanghai Lishan Biopharmaceuticals
- Shanghai Pharmaceutical
- Sharp HealthCare
- Shasqi
- Sheba Medical Center
- Shenzhen Chipscreen Biosciences
- Shepherd Therapeutics
- Shine Medical Technologies
- SHINE Technologies
- Shoreline Biosciences
- Shorla Oncology
- Shorla Pharma
- Showa Denko
- Shuttle Pharmaceuticals
- Sibylla Biotech
- Sidewinder Therapeutics
- Sidney Kimmel Cancer Center
- Siemens Healthineers
- Sierra Oncology
- SIGA Technologies
- Signify Health
- Silexion Therapeutics
- SillaJen
- SimBioSys
- Simcere Pharmaceutical
- Simcere Zaiming
- Simcha Therapeutics
- Similis Bio
- Simnova
- Simsen Diagnostics
- Simulations Plus
- Singapore General Hospital
- Singlera Genomics
- Singleron Biotechnologies
- Singular Genomics Systems
- Sino-American Cancer Foundation
- Sino Biopharm
- Sinorda Biomedicine
- Sirona Dx
- Sirona Medical
- Sirtex Medical
- SiSaf
- SK Biopharmaceuticals
- Skin and Cancer Institute
- SkyePharma
- Skyhawk Therapeutics
- SkylineDX
- Smart Immune
- SN BioScience
- Societal CDMO
- Solaris
- Soligenix
- Solis Mammography
- Solstice Oncology
- Solve Therapeutics
- SomaLogic
- Sona Nanotech
- Sonnet BioTherapeutics
- Sonrai Analytics
- Sony
- Sookmyung Women's University
- SOPHiA Genetics
- Sorrento Therapeutics
- Sosei Heptares
- SOTERIA Precision Medicine Foundation
- SOTIO
- Southern Oncology Specialists
- Spanios
- Spanish Lung Cancer Group
- Spanish National Cancer Research Centre
- Spanish National Research Council
- Spanish State Research Agency
- SparX Biopharmaceutical
- Specialised Therapeutics
- SpectronRx
- Spectrum Pharmaceuticals
- Spectrum Solutions
- Spesana
- SpotitEarly
- SpringWorks Therapeutics
- Sprint Biosciences
- St. Baldrick's Foundation
- St. Jude Children's Research Hospital
- Stablepharma
- STADA Arzneimittel
- Stand Up To Cancer
- Stanford University
- Stanford University School of Medicine
- StarkAge Therapeutics
- Starpharma
- Starton Therapeutics
- Statera Biopharma
- Stella Diagnostics
- Stemline Therapeutics
- Stem of Hope
- Step Pharma
- SteroTherapeutics
- Stimunity
- Stipple Bio
- Storm Therapeutics
- Strand Therapeutics
- Strata Oncology
- SUDA Pharmaceuticals
- Summit Therapeutics
- Summus
- Sunnybrook Research Institute
- Sun Pharma Advanced Research Company
- Sun Pharmaceutical
- SunRock Biopharma
- Sunshine Biopharma
- Sunstone Therapies
- Surface Oncology
- Susan G. Komen for the Cure
- Sutro Biopharma
- Suzhou Porton Advanced Solutions
- Suzhou Puhe BioPharma
- Suzhou Runxin Biotechnology
- Swedish Orphan Biovitrum
- Swiss Institute of Bioinformatics (SIB)
- Swiss Pharmaceutical
- Swiss Rockets
- Syapse
- Syena
- Synaffix
- Syncromune
- Syndax Pharmaceuticals
- SynDevRx
- Syndivia
- Syneos Health
- Syngene
- Synimmune
- Synnovation Therapeutics
- Synthekine
- Syros Pharmaceuticals
- Sysmex
- Sysmex Inostics
- Systimmune
- T-Cure Bioscience
- Tachyon Therapeutics
- TAE Life Sciences
- Tahoe Therapeutics
- Taiho
- Takeda Oncology
- Takeda Pharmaceutical
- Talem Therapeutics
- Tallac Therapeutics
- Talus Bioscience
- Tampa General Hospital Cancer Institute
- Targovax
- Tasly Pharmaceuticals
- Tavotek Biotherapeutics
- Tavros Therapeutics
- TC BioPharm
- Tcelltech
- TCG Labs Soleil
- TCR2 Therapeutics
- TeamConnor Childhood Cancer Foundation
- Techcyte
- Tegmine Therapeutics
- Tel Aviv University
- Telix Pharmaceuticals
- Tella
- Tempest Therapeutics
- Tempus
- Tennessee Oncology
- Tentarix Biotherapeutics
- Teon Therapeutics
- TeraRecon
- Terray Therapeutics
- TerThera
- Terumo
- Terumo Blood and Cell Technologies
- Tesaro
- Tesis Biosciences
- Tessa Therapeutics
- Tessellate Bio
- Teva Pharmaceutical Industries
- Texas Oncology
- Texcell
- TFC Therapeutics
- TGen Drug Development
- Tharimmune
- The Parker Institute For Cancer Immunotherapy
- Therabest
- Theragen
- Theragent
- Theragnostics
- Theralase
- Theralink Technologies
- Therapeutic Solutions International
- Therapixel
- Theratechnologies
- Theriva Biologics
- Thermo Fisher Scientific
- Theryq
- Theseus Pharmaceuticals
- The Technical University Of Munich
- ThinkCyte
- ThinkingNodeLife
- Third Arc Bio
- Thomas Jefferson University
- Three Rivers Provider Network
- Tigerlily Foundation
- TILT Biotherapeutics
- Tiziana Life Sciences
- TJ Biopharma
- Tolmar
- Totus Medicines
- Touchlight
- Tracer Biotechnologies
- TRACON Pharmaceuticals
- Transcenta
- TransCode Therapeutics
- Transgene
- Translational Genomics Research Institute
- TransThera
- TransThera Sciences
- Traverse Biosciences
- Treadwell Therapeutics
- TreeFrog Therapeutics
- Treehill Partners
- Treeline Biosciences
- Treventis
- Trialbee
- TRIANA Biomedicines
- Trigone Pharma
- TRIGR Therapeutics
- Trinity Biotech
- Trinity College Dublin
- TriSalus Life Sciences
- Triumvira Immunologics
- Trusted Health Advisors
- TScan Therapeutics
- TTC
- Tubulis
- TuHURA Biopharma
- TuHURA Biosciences
- TumorGen
- Turbine
- Turn Biotechnologies
- Turning Point Therapeutics
- Turnstone Biologics
- TwinStrand Biosciences
- Twinstrand Therapeutics
- Twist Bioscience
- TYG Oncology
- Ubiquigent
- Ubix Therapeutics
- uBriGene Biosciences
- U CAN-CER VIVE Foundation
- UCB
- UK Government
- Ultima Genomics
- Umoja Biopharma
- Undisclosed Company
- Unilabs
- Unio Health Partners
- Uni Targeting Research
- United Immunity
- Univeristy of Durham
- Universal Cells
- Universal DX
- Universite Laval
- University College London
- University Health Network
- University Hospital Magdeburg
- University Hospitals Case Medical Center
- University Libre of Brussels
- University Medical Center Utrecht
- University of Alabama at Birmingham
- University of Antwerp
- University of Arkansas
- University of Augsburg
- University of Barcelona
- University of Bern
- University of Birmingham
- University of Bordeaux I
- University of British Columbia
- University of Calgary
- University of California
- Davis
- University of California
- San Diego
- University of California Berkeley
- University of California Irvine
- University of California Los Angeles
- University of California San Francisco
- University of California Santa Barbara
- University of Cambridge
- University of Central Florida Research Foundation
- University of Chicago
- University of Colorado
- University of Dundee
- University of Edinburgh
- University of Florida
- University of Glasgow
- University of Granada
- University of Heidelberg
- University of Illinois
- University of Illinois Urbana-Champaign
- University of Iowa
- University of Jaen
- University of Kansas
- University of Lausanne
- University of Leeds
- University of Leipzig
- University of Louisville
- University of Manchester
- University of Marburg
- University of Maryland
- University of Maryland Baltimore
- University of Massachusetts
- University of Miami
- University of Michigan
- University of Milano-Bicocca
- University of Minnesota
- University of Missouri
- University of Montreal
- University of Newcastle
- University of New Mexico
- University of New South Wales
- University of North Carolina
- University of Oulu
- University of Oxford
- University of Pennsylvania
- University of Pittsburgh
- University of Quebec
- University of Queensland
- University of Rochester
- University of Rochester Medical Center
- University of Sheffield
- University of Southampton
- University of South Australia
- University of South Carolina
- University of Sydney
- University of Texas
- University of Texas Health SCience Center at San Antonio
- University of Texas Southwestern Medical Center
- University of Tulsa
- University of Utah
- University of Virginia
- University of Washington
- University of Wisconsin
- University of Wisconsin Carbone Cancer Center (UWCCC)
- University of Wollongong
- Unleash Immuno Oncolytics
- Unnatural Products
- Unravel Biosciences
- UroGen Pharma
- UroGPO
- UroViu
- US Government
- US Medical Innovations
- US Oncology Research
- US WorldMeds
- UT Southwestern Medical Center
- Valence Discovery
- Valion Bio
- Vall d’Hebron Research Institute
- Valo Therapeutics
- Vanderbilt University
- Varian Medical Systems
- Vaxalto Biotherapeutics
- Vaximm
- VBI Vaccines
- Vector Pharma FZCO
- Vectura
- Veeva Systems
- Vela Diagnostics
- VelaVigo
- Velocity Bioworks
- Veracyte
- Verastem
- Veraxa Biotech
- Verily
- VerImmune
- VeriSIM Life
- Verismo Therapeutics
- Vernalis
- Versiti Blood Research Institute
- Vertex Pharmaceuticals
- Veru
- VIB
- Vibliome Therapeutics
- Vida Diagnostics
- VieCure
- ViennaLab Diagnostics
- Viewpoint Molecular Targeting
- Vignette Bio
- Vincere Cancer Center
- Vinnova
- Viome
- Vipergen
- Vir Biotechnology
- ViroCell Biologics
- Virogen
- Visiopharm
- Vittoria Biotherapeutics
- ViVerita Therapeutics
- Vividion Therapeutics
- Volastra Therapeutics
- VolitionRX
- Volpara Health Technologies
- Volpara Solutions
- Voltron Therapeutics
- Vor Biopharma
- Voronoi
- Voro Therapeutics
- Vuja De Sciences
- VyGen-Bio
- VYNE Therapeutics
- Vyriad
- Vysioneer
- Waiv
- Wake Forest University
- Walgreens
- Wanchunbulin
- Warpnine
- Waseda University
- Washington University in St Louis
- Watchmaker Genomics
- Waters Corporation
- Weill Cornell Medical College
- Weizmann Institute
- WellDyne
- Wellmarker Bio
- Welton Pharma
- Werewolf Therapeutics
- West German Study Group
- Whitehawk Therapeutics
- White Lion Capital
- Whitman-Walker Institute
- Wilmot Cancer Institute
- Wilson Wolf
- Windber Research Institute
- Wisconsin Alumni Research Foundation
- Wonkwang University
- Worldwide Clinical Trials
- WUGEN
- Wuxi Apptec Laboratory Services
- WuXi Biologics
- Wuxi STA
- WuXi XDC
- WY Biotech
- Wyss Institute
- XBiotech
- Xcell Biosciences
- xCures
- Xencor
- Xenetic Biosciences
- Xiamen Biotime Biotechnology
- Xilio Therapeutics
- Xilis
- XNK Therapeutics
- Xspray Pharma
- XtalPi
- Xuanzhu Biopharma
- Xylyx Bio
- Xyphos Biosciences
- Y-Biologics
- Y-mAbs Therapeutics
- Yale Cancer Center
- Yale School of Medicine
- Yale University
- Yantai Lannacheng Biotechnology
- Yatiri Bio
- Yeda Research and Development Company
- Yemaachi Biotech
- Yingli Pharma
- Yissum Research Development
- Ymmunobio
- Yuhan Corporation
- YUMAB
- Zai Lab
- ZAI Laboratory
- Zelgen
- Zelluna Immunotherapy
- Zenith Epigenetics
- Zentalis Pharmaceuticals
- Zephyr AI
- Zerion Pharma
- Zetagen Therapeutics
- Zhejiang Doer Biotechnology
- Zion Pharmaceuticals
- Zonsen PepLib Biotech
- Zumutor Biologics
- Zydus Lifesciences
- Zymeworks
- ZYUS Life Sciences
Methodology
- The publisher reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
- The publisher reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
- The publisher analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
- The publisher reports source deal data from our proprietary deals and alliances database. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal.
- The data in the deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.
The publisher provides comprehensive coverage of the following partnering or deal types:
- Asset purchase
- Assignment
- Co-development
- Co-market
- Co-promotion
- Collaborative R&D
- Contract service
- CRADA
- Cross-licensing
- Development
- Distribution
- Equity purchase
- Evaluation
- Grant
- Joint venture
- Licensing
- Loan
- Manufacturing
- Marketing
- Option
- Promotion
- Research
- Royalty financing
- Settlement
- Spin out
- Sub license
- Supply
- Termination
- Warrant
Every deal record is fully categorized and includes the following data, where available:
- Industry sector
- Therapy areas
- Technology type
- Deal components
- Financial terms
- Stage of development
- Exclusivity
- Asset type
- Geographic focus
- Excluded geography
- Company press release
- SEC filing data including contract document
All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.
LOADING...
